Article ID Journal Published Year Pages File Type
6199536 Ophthalmology 2015 7 Pages PDF
Abstract
These analyses suggest that there are subgroups of patients for whom VA outcomes in the second year of the VIEW studies were less stable than in the first year and for whom W52 seems to be an important inflection point. Although alternate reasons specific to the nature of the underlying AMD cannot be fully excluded, the switch in treatment regimen at W52 is a plausible explanation.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , , , , , , , , , , ,